It’s about the gain! Celebrating International Alopecia Day 2022
The first Saturday in August is International Alopecia Day. This year, we're reflecting on what we've gained due to hair loss. Find out how you can join us on social media #internationalalopeciaday2022 #canaaf2022.
Concert Pharmaceuticals CTP‑543: Is a second FDA-approved treatment for alopecia areata on its way?
Concert Pharmaceuticals reports more positive topline results for CTP-543 as they prepare to submit for FDA approval in the first half of 2023. How exciting!
CANAAF Come Together 2022 Conference: The weekend we won’t forget!
Take a look at some of the exciting moments from this past weekend at CANAAF's Come Together 2022 Conference in Toronto. We had a blast!
Jessica overcomes the odds and gives back to Sick Kids
24-year-old Jessica Rotolo from Toronto has big plans to increase awareness of alopecia areata with a documentary about her life. Here's why her film director, Scott Drucker, believes this is a story that needs to be heard.
Welcoming Camp Summit: Canada’s first summer camp for children with alopecia areata!
CANAAF is proud to announce a new Ontario summer camp for children with alopecia areata in partnership with Camp Maple Leaf. Learn more.
Exciting news! Olumiant (baricitinib) has finally been approved as a treatment for Alopecia Areata!
On June 13th, a JAK inhibitor called Olumiant became the first FDA-approved treatment for alopecia areata. Read more and find out what this means for Canadians.